Notably, the mRNA expression of peripheral blood ALKBH5 in 7 of the RA patients increased following the treatment when compared with those prior to treatment, and 2 RA patients had decreased mRNA expression of peripheral blood ALKBH5. The gene discussed is ALKBH5; the disease is rheumatoid arthritis.